Manchikanti Laxmaiah, Hirsch Joshua A
Pain Management Center of Paducah, 2831 Lone Oak Road, Paducah, KY, 42003, USA,
Curr Pain Headache Rep. 2015 May;19(5):482. doi: 10.1007/s11916-015-0482-3.
Multiple case reports of neurological complications resulting from intraarterial injection of corticosteroids have led the Food and Drug Administration (FDA) to issue a warning, requiring label changes, warning of serious neurological events, some resulting in death. The FDA has identified 131 cases of neurological adverse events, including 41 cases of arachnoiditis. A review of the literature reveals an overwhelming proportion of the complications are related to transforaminal epidural injections, of which cervical transforaminal epidural injections constituted the majority of neurological complications. Utilization data of epidural injections in the Medicare population revealed that cervical transforaminal epidural injections constitute only 2.4 % of total epidural injections and <5 % of all transforaminal epidural injections. Multiple theories have been proposed as the cause of neurological injury including particulate steroid, arterial intimal flaps, arterial dissection, dislodgement of plaque causing embolism, arterial muscle spasm, and embolism of a fresh thrombus following disruption of the intima.
动脉内注射皮质类固醇导致神经并发症的多例病例报告促使美国食品药品监督管理局(FDA)发布警告,要求更改标签,警示严重的神经事件,其中一些可导致死亡。FDA已确认131例神经不良事件,包括41例蛛网膜炎。文献回顾显示,绝大多数并发症与经椎间孔硬膜外注射有关,其中颈椎经椎间孔硬膜外注射导致的神经并发症占多数。医疗保险人群硬膜外注射的使用数据显示,颈椎经椎间孔硬膜外注射仅占硬膜外注射总数的2.4%,占所有经椎间孔硬膜外注射的比例不到5%。关于神经损伤的原因已提出多种理论,包括颗粒状类固醇、动脉内膜瓣、动脉夹层、斑块脱落导致栓塞、动脉肌肉痉挛以及内膜破裂后新鲜血栓的栓塞。